XML 41 R35.htm IDEA: XBRL DOCUMENT v3.26.1
NET LOSS PER SHARE OF COMMON STOCK - Securities Excluded from Calculation of Weighted Average Shares Outstanding as their Effect is Antidilutive (Parenthetical) (Details) - shares
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Preferred stock, shares outstanding 0 0
Series A Preferred Stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Preferred stock, shares outstanding 3,296  
Conversion of stock converted 1,559,008  
Series A Preferred Stock | Tranche A Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Conversion of stock converted 37,272,400  
Issuance of common stock 78,800  
Series A Preferred Stock | Tranche B Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Conversion of stock converted 18,920,000  
Issuance of common stock 40,000